Mode
Text Size
Log in / Sign up

Higher prepregnancy HOMA-IR quartiles associated with lower clinical pregnancy and live-birth rates in PCOSInsulin resistance levels impact pregnancy success for women with PCOS

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that higher prepregnancy HOMA-IR quartiles are associated with lower clinical pregnancy and live-birth rates in PCOS.

This secondary analysis of a multicenter randomized trial included 746 women aged 18 to 40 years with polycystic ovarian syndrome (PCOS) undergoing ovulation induction. The study evaluated the impact of prepregnancy insulin resistance, measured by HOMA-IR, QUICKI, and glucose-to-insulin ratio, on reproductive outcomes.

Results showed a significant negative association between prepregnancy HOMA-IR quartiles and ovulation rates (93.5% vs 87.8% vs 75.4% vs 73.8%; P <.001). Clinical pregnancy rates were also lower in higher HOMA-IR quartiles (36% vs 25.5% vs 23.52% vs 26.5%; P =.005). Live-birth rates were significantly lower in higher HOMA-IR quartiles (35.5% vs 19.7% vs 20.3% vs 18.2%; P <.001). Conversely, higher HOMA-IR quartiles were associated with a higher risk of gestational diabetes mellitus (13.8% vs 15.4% vs 22.5% vs 45.7%; P =.002).

Improvement in HOMA-IR during treatment was associated with increased odds of clinical pregnancy and reduced risk of preeclampsia. No specific safety or tolerability data were reported. The study is a secondary analysis of a randomized trial, and results are based on HOMA-IR quartiles. These findings suggest that addressing insulin resistance before fertilization may improve reproductive success and reduce obstetric risks in the PCOS population.

How this fits prior evidence

How this fits prior evidence: This finding extends the clinical understanding of PCOS management by linking insulin resistance to specific reproductive outcomes. While previous coverage noted that a Letrozole protocol was associated with higher live birth and lower adverse outcomes in ovulation disorder FET, this study specifically highlights how prepregnancy HOMA-IR quartiles correlate with lower live-birth rates (35.5% vs 19.7% vs 20.3% vs 18.2%) and lower clinical pregnancy rates. It also addresses the impact of insulin resistance on gestational diabetes risk.

For women with Polycystic Ovarian Syndrome (PCOS) trying to conceive, the road to pregnancy can be complicated by how the body handles insulin. Insulin is a hormone that helps your body use sugar for energy. When your body becomes resistant to it, it can interfere with ovulation and overall reproductive health.

A study of 746 women found that higher levels of insulin resistance before starting treatment were linked to lower rates of ovulation and fewer clinical pregnancies. Specifically, women in the highest group for insulin resistance showed a 26.5% pregnancy rate, while those in the lowest group had a 36% rate. These higher levels were also linked to lower live birth rates.

On a positive note, the study found that improving insulin resistance during treatment was linked to better odds of pregnancy and a lower risk of preeclampsia, a serious blood pressure condition during pregnancy. While these results show a clear link between insulin and pregnancy outcomes, it is important to remember that this was a secondary analysis of a trial. These findings show a connection, not a direct cause, and your doctor can help determine the best path for your specific needs.

What this means for you:
Improving insulin resistance before and during treatment may help improve pregnancy success for women with PCOS.

Common questions

How does insulin resistance affect pregnancy for women with PCOS?

Higher levels of insulin resistance before treatment are linked to lower ovulation rates and lower clinical pregnancy rates. For example, women with the highest insulin resistance had a 26.5% pregnancy rate, while those with the lowest levels had a 36% rate. These higher levels were also linked to lower live birth rates.

Can improving insulin resistance help during my treatment?

Yes, the study found that improving insulin resistance during treatment was associated with increased odds of clinical pregnancy. It was also linked to a reduced risk of preeclampsia, which is a serious condition involving high blood pressure during pregnancy.

What are the risks of high insulin resistance during pregnancy?

Women with higher levels of insulin resistance before pregnancy showed a higher risk of developing gestational diabetes mellitus (GDM). The risk increased significantly in the highest group, reaching 45.7% compared to 13.8% in the lowest group.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up480.0 mo
PublishedOct 2026
View Original Abstract ↓
OBJECTIVE: To determine whether prepregnancy insulin resistance and its improvement during ovulation induction are associated with fertility and pregnancy outcomes in women with polycystic ovarian syndrome (PCOS). METHODS: This secondary analysis used data from PPCOS II (Pregnancy in Polycystic Ovary Syndrome II), a multicenter randomized trial. This analysis included women aged 18-40 years with PCOS who were undergoing ovulation induction with clomiphene citrate or letrozole. Insulin resistance was assessed at screening and at end-of-treatment visits by using the homeostatic model assessment of insulin resistance (HOMA-IR), the quantitative insulin sensitivity check index, and the glucose-to-insulin ratio. The primary outcome was clinical pregnancy, and secondary outcomes included gestational diabetes mellitus (GDM), preeclampsia, and preterm delivery. RESULTS: Among 746 women, higher prepregnancy HOMA-IR quartiles were associated with decreased ovulation (93.5% vs 87.8% vs 75.4% vs 73.8%; P <.001, P for trend <.001), lower clinical pregnancy (36% vs 25.5% vs 23.52% vs 26.5%; P =.005, P for trend=.001) and live-birth rates (35.5% vs 19.7% vs 20.3% vs 18.2%; P <.001, P for trend <.001), and higher risk of GDM (13.8% vs 15.4% vs 22.5% vs 45.7%; P =.002, P for trend <.001). Women in the highest HOMA-IR quartiles experienced delayed first ovulation and more frequent obstetric complications, especially increased risks of GDM. Improvement in the HOMA-IR during treatment was associated with increased odds of clinical pregnancy and reduced risk of preeclampsia. CONCLUSION: Prepregnancy insulin resistance is associated with impaired fertility and increased pregnancy complications in women with PCOS. Assessment and improvement of insulin resistance before fertilization may enhance reproductive success and reduce obstetric risk. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov , NCT00719186.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.